DHR
Danaher Corporation
·
$203.83
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Terminal终端 ↗
Danaher Corporation · Health Care
DHR
$203.83
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics.丹纳赫公司是一家总部位于华盛顿特区的美国医疗保健公司，开发用于生物技术、生命科学和诊断领域的产品。
Mixed profile混合特征
Large cap大盘
$144B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
You missed the bottoming entry — the low already formed and price is now extended (momentum is fading — the daily moment已错过筑底入场——低点已经形成，目前价格已拉伸（动量正在衰竭——日线动量已开始掉头向下）。不要追高；等待回调至 10 日均线或下一个周期低点。若已持有则继续持有。
Price Chart价格图表
Key Statistics关键统计
Price价格
$203.83
15.4% below 52-week high低于52周高点 15.4%
Market Cap市值
$144B
Normal volume正常成交量
P/E Ratio市盈率
39.9x
28.9x sector median
Forward P/E预测市盈率
22.1x
EPS每股收益 $5.11
Beta贝塔
0.58
Moves about 0.6x the market波动幅度约为市场的 0.6 倍
Dividend Yield股息收益率
0.78%
RSI (14)RSI（14）
66
Elevated偏高
Next Earnings下次财报
2026-07-28 (9d)
Volatility Rank波动率分位
59th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
1.5% of float
Performance价格表现
| Period周期 | DHR | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +2.4% | -1.5% | Beat the index by 3.9 points跑赢指数 3.9 个百分点 |
| 1 Month近1月 | +14.9% | +0.6% | Beat the index by 14.3 points跑赢指数 14.3 个百分点 |
| 3 Months近3月 | +4.9% | +4.7% | In line with the index与指数基本持平 |
| 6 Months近6月 | -13.3% | +7.8% | Lagged the index by 21.1 points落后指数 21.1 个百分点 |
| Year to date年初至今 | -11.2% | +9.1% | Lagged the index by 20.3 points落后指数 20.3 个百分点 |
| 1 Year近1年 | +5.4% | +19.4% | Lagged the index by 14.0 points落后指数 14.0 个百分点 |
| 3 Years近3年 | -2.9% | +69.4% | Lagged the index by 72.3 points落后指数 72.3 个百分点 |
| 5 Years近5年 | -17.3% | +83.9% | Lagged the index by 101.2 points落后指数 101.2 个百分点 |
Technicals技术面
Active signals活跃信号
1-Day Return (cross-sectional rank → top/bottom gainers)Valuation cheapness percentile (0–1, higher = cheaper vs peers)Insider Power (0–100) — quality-weighted Form-4 open-market trades (role × size × recency); 50 = neutralInsider Sell signal — fires when Insider Power ≤ 40 (net selling on quality-weighted basis)Ichimoku — Price Above Cloud
RSI (14)RSI（14）
66
Elevated偏高
vs 50-day相对50日均线
+11.7% vs 50-day avg
vs 200-day相对200日均线
+0.1% vs 200-day avg
Trend strength (ADX)趋势强度（ADX）
29
Trending趋势中
Volatility rank波动率分位
59th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$195.80
Don't chase above不追高于
$203.80
Stop止损
$176.80
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
9
days until next report天后公布财报
2026-07-28
Estimates being raised — 2 analysts预期上调 — 2 位分析师
Post-earnings drift: -12.1% (20d)财报后漂移：-12.1%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | DHR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 39.87x | 28.92 | 27% |
| P/E (forward)市盈率（预测） | 22.1x | — | — |
| P/B市净率 | 2.74x | 3.52 | 62% |
| P/S市销率 | 5.86x | 3.02 | 26% |
| Earnings yield盈利收益率 | 2.51% | 2.72 | 46% |
| FCF yield自由现金流收益率 | 3.65% | 3.94 | 44% |
| Shareholder yield股东收益率 | 2.14% | 1.89 | 54% |
| EV/EBITDA企业价值/EBITDA | 29.02x | 18.21 | 22% |
| P/FCF市值/自由现金流 | 27.39x | 22.42 | 35% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 2.0%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 0.6%
Free Cash Flow自由现金流
Margins利润率
6.9%Return on Equity股本回报率
4.3%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 2.54 |
| Current ratio流动比率 | 1.87 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $3.1B |
| Stock-based comp股权薪酬 | $298.0M |
| Share count change (1y)股数变化（1年） | -1.7% |
Piotroski皮奥特罗斯基 5/9
Altman Z阿尔特曼Z: safe (4.2)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 36% of its sector on blended multiples综合估值倍数低于行业内 36% 的公司
Beta市场敏感度
0.58×
0.21×3×
Moves about 0.6× the market波动幅度约为市场的 0.6 倍
Financial Health财务健康
5/9
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
0.78%
Pays a dividend (0.78% yield)有分红（收益率 0.78%）
Why Is It Moving为何波动
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健（等权）」主题 — 46 个主题中第 6 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
DHR reclaimed its 200-day averageDHR 收复200日均线
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.32%
Expected weekly move预期周波动
±5.19%
Call wall看涨密集区
$220
Put wall看跌密集区
$192
Gamma flip伽玛翻转
$168
25d risk reversal25d风险逆转
-4.2%
Skew: 偏斜：fear
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$244.9M net (0 buyers, 6 sellers)-$244.9M 净值（0 买家，6 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| D1 Capital Partners | A | Adding加仓 | 3.9% | 2026-03-31 |
| Gates Foundation Trust | D | Holding持有 | 0.2% | 2026-03-31 |
| Dorsey Asset Management | B | trimtrim | 8.8% | 2026-03-31 |
| Third Point (Loeb) | B | trimtrim | 4.8% | 2026-03-31 |
| Akre Capital Management | C | exitexit | 0.0% | 2026-03-31 |
| Perceptive Advisors | A | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TOP WATCH
NEARING A HIGH
Jul 16, 2026
DHR reclaimed its 200-day averageDHR 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $205.01.收盘重回200日均线 — 经典的多头分界线。$205.01。
Jul 15, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 13, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jul 9, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jul 8, 2026
BUY ZONE → NEARING A LOW买入区 → 接近低点
GET READY准备
Jul 1, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jun 30, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Showing last 15 of显示最近15条，共 3881 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.17
Value价值
-0.4
Profitability盈利能力
-0.8
Quality质量
+0.0
Investment资本投入
+0.1
Shareholder payout股东回报
-0.5
Low volatility低波动
+0.7
Low market beta低市场敏感度
+0.3
Earnings quality盈利质量
-0.2
Short interest空头兴趣
+1.0
Company Profile公司档案
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics.丹纳赫公司是一家总部位于华盛顿特区的美国医疗保健公司，开发用于生物技术、生命科学和诊断领域的产品。
Demand chain:需求链： Contracted bookings (RPO) accelerating (+21% YoY to ~$5B, 0.2× revenue) — signed demand locked in ahead of recognition已签约订单（RPO）加速（同比+21%，约 $5B，覆盖营收 0.2 倍）——已锁定、尚未确认的需求
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。